Presently, Olaf Schermeier occupies the position of CEO-Global Research & Development at Fresenius Medical Care AG & Co. KGaA and Chairman-Supervisory Board at Xenios AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA).

He is also on the board of Medos Medizintechnik AG and Member-Management Board at Fresenius Medical Care Management AG and Member of Stifterverband für die Deutsche Wissenschaft eV.

In his past career Olaf Schermeier occupied the position of Development Engineer at Robodent GmbH, Manager-Strategic Product Planning at BIOTRONIK SE & Co. KG, President-Global Research & Development at Dräger Medical GmbH and Research Engineer at Charité - Universitätsmedizin Berlin.

Olaf Schermeier received a doctorate from Technical University of Berlin and an undergraduate degree from the University of Hannover.